Defender Capital, Llc. Palatin Technologies Inc Transaction History

Defender Capital, Llc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 29, 2021	SELL	$0.48 - $0.72 $4,800 - $7,200	-10,000 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$0.68 - $1.25 $6,800 - $12,500	10,000 New	10,000 $2.32 Million

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.48M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Defender Capital, Llc., based on Form 13F filings with the SEC.

Stay updated on Defender Capital, Llc. with notifications on news.